Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

International Journal of Molecular Sciences(2025)10.3390/ijms26189041Source: DataRank Database

BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma? is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.41)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Aditi Jain ORCID,Lily Zekavat

Live enrichment

PubMed:41009605 PMC:PMC12470959 OpenAlex:https://openalex.org/W4414280787

Pancreatic Cancer Action Network-Career Development Award

Grant: 21-20-JAIN

Pancreatic Cancer Action Network-Career Development Award

Grant: 1R03CA283232-01

Elucidating the relevance of BARD1-PLK1 interaction in PDAC and response to therapy

NCI NIH HHS

Grant: R03 CA283232

FWCI

0.41

Citation Percentile

0.6%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/26/18/9041/pdf?version=1758098125

publisherhttps://www.mdpi.com/1422-0067/26/18/9041/pdf?version=1758098125

publisherhttps://www.mdpi.com/1422-0067/26/18/9041/pdf

journalhttps://doi.org/10.3390/ijms26189041

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41009605

Fields of Study

DNA Repair MechanismsPARP inhibition in cancer therapyCancer therapeutics and mechanisms03 medical and health sciences0302 clinical medicineHumansCarcinoma, Pancreatic DuctalUbiquitin-Protein LigasesPancreatic NeoplasmsTumor Suppressor ProteinsAnimalsDNA RepairApoptosisDNA DamageProtein IsoformsDrug Resistance, Neoplasm

MeSH Terms

AnimalsDNA DamageDNA RepairHumansPancreatic NeoplasmsApoptosisDrug Resistance, NeoplasmProtein IsoformsCarcinoma, Pancreatic DuctalTumor Suppressor ProteinsUbiquitin-Protein Ligases

Keywords

Pancreatic ductal adenocarcinomaDNA repairDNA damageSuppressorHomologous recombinationMalignancyPancreatic cancerReviewDouble-strand Break RepairBard1PdacBrca1-bard1Ubiquitin-Protein LigasesTumor Suppressor ProteinsApoptosisPancreatic NeoplasmsDrug Resistance, NeoplasmHumansAnimalsProtein IsoformsCarcinoma, Pancreatic Ductal

BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

FAIR Checklist

Authors (2)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)